Cancer Care Ontario | Action Cancer Ontario

906 Results

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Mar 2025

Test de la voûte vaginale

Drug

treosulfan

Other Name(s): Trecondyv®

Quick Link(s):

Drug Monograph

Jan 2025

Document

[PDF]

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

Dec 1969

Document

[PDF]

Ontario-Cervical-Screening-Program-Transition-Guidance-for-ages-21-24.pdf

Dec 1969

Document

[PDF]

Ontario-Cervical-Screening-Program-Guidance-for-Vaginal-Vault-Testing.pdf

Dec 1969

Ontario Cancer Profiles – Frequently Asked Questions

Document

[PDF]

OCS2024.pdf

Mar 2025

Document

[PDF]

OCS2024_Excel-workbook_Figures.xlsx

Mar 2025

Document

[PDF]

OCS2024_Excel-workbook_Tables.xlsx

Mar 2025

Document

[PDF]

OCS2024-FR.pdf

Mar 2025

Document

[PDF]

OCS2024-Excel-workbook-Figures-Fr.xlsx

Mar 2025

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Test de la voûte vaginale

treosulfan

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

Ontario-Cervical-Screening-Program-Transition-Guidance-for-ages-21-24.pdf

Ontario-Cervical-Screening-Program-Guidance-for-Vaginal-Vault-Testing.pdf

Ontario Cancer Profiles – Frequently Asked Questions

OCS2024.pdf

OCS2024_Excel-workbook_Figures.xlsx

OCS2024_Excel-workbook_Tables.xlsx

OCS2024-FR.pdf

OCS2024-Excel-workbook-Figures-Fr.xlsx

Pages